The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific
- 1 November 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 102 (11), 1095-1101
- https://doi.org/10.1016/j.trstmh.2008.04.024
Abstract
Summary. Tafenoquine is being developed for radical cure and post-exposure prophylaxis of Plasmodium vivax malaria. In an open-label study, 1512 Australian DefKeywords
This publication has 15 references indexed in Scilit:
- PRIMAQUINE: REPORT FROM CDC EXPERT MEETING ON MALARIA CHEMOPROPHYLAXIS IThe American Journal of Tropical Medicine and Hygiene, 2006
- Adequate Primaquine for Vivax MalariaJournal of Travel Medicine, 2006
- A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Ranging Trial of Tafenoquine for Weekly Prophylaxis againstPlasmodium falciparumClinical Infectious Diseases, 2003
- Comparison of tafenpquine (WR238605) and primaquine in the post-exposure (terminal) prophylaxis of vivax malaria in Australian Defence Force personnelTransactions of the Royal Society of Tropical Medicine and Hygiene, 2002
- Tolerability of doxycycline monohydrate salt vs. chloroquine–proguanil in malaria chemoprophylaxisTropical Medicine & International Health, 2002
- Population pharmacokinetics of the new antimalarial agent tafenoquine in Thai soldiersBritish Journal of Clinical Pharmacology, 2001
- The neglected burden of Plasmodium vivax malariaThe American Journal of Tropical Medicine and Hygiene, 2001
- Measurement of Tafenoquine (WR 238605) in Human Plasma and Venous and Capillary Blood by High-Pressure Liquid ChromatographyTherapeutic Drug Monitoring, 2000
- First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial.The American Journal of Tropical Medicine and Hygiene, 1998
- Pharmacokinetics of an extended-dose halofantrine regimen in patients with malaria and in healthy volunteers*Clinical Pharmacology & Therapeutics, 1995